This Article  • Full text  • PDF  • Correction  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (5)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Choroidal Neovascularization  • Public Health  • Public Health, Other  • Quality of Life  • Alert me on articles by topic  Social Bookmarking   What's this?

Findings in Patients With Subfoveal Choroidal Neovascularization—SST Report No. 1

The Submacular Surgery Trials Research Group

Arch Ophthalmol. 2003;121:531-539.

ABSTRACT
Background  The National Eye Institute Visual Function Questionnaire (NEI-VFQ) measures vision-targeted quality of life, but it is unclear whether it is sensitive to changes within individuals over time.

Objective  To determine the responsiveness of the NEI-VFQ to "within-individual" changes in visual acuity in patients who had subfoveal choroidal neovascularization in at least one eye secondary to age-related macular degeneration, ocular histoplasmosis syndrome, or idiopathic causes, and who participated in randomized trials of submacular surgery.

Methods  Trained telephone interviewers administered the NEI-VFQ as part of annual follow-up data collection for pilot trials and larger clinical trials of submacular surgery. Best-corrected visual acuity was measured by local vision examiners at 12 months after enrollment and, typically, by central "traveling" vision examiners at 24 months after enrollment. Changes in visual acuity and NEI-VFQ scores from 12 to 24 months were analyzed using linear regression methods.

Results  Two-hundred eighteen patients had both interviews and visual acuity measurements at 12 and 24 months after enrollment. Changes in the overall NEI-VFQ score and in 9 of the subscales (near activities, dependency, driving, role difficulties, distance activities, mental health, general vision, peripheral vision, and social functioning) were related to changes in visual acuity of the better-seeing eye based on linear regression analysis (P<.05). In our analysis, a 3-line decrease in the visual acuity of the better-seeing eye was associated with 3.6- to 16.2-point decreases in the overall NEI-VFQ score and 9 subscale scores.

Conclusions  Most of the NEI-VFQ subscales were responsive to changes in the visual acuity of the better-seeing eye over a 12-month interval in this patient population. Thus, the NEI-VFQ can be used to measure change in vision-targeted quality of life over time to augment clinical measurements of visual acuity.

The authors for the Submacular Surgery Trials Research Group are Päivi H. Miskala, PhD, Barbara S. Hawkins, PhD, Carol M. Mangione, MD, MSPH, Eric B. Bass, MD, MPH, Neil M. Bressler, MD, Li Ming Dong, PhD, Marta J. Marsh, MS, and Lee D. McCaffrey, MA.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Reliability and Validity of the National Eye Institute Visual Function Questionnaire-25 in Patients with Age-Related Macular Degeneration
Revicki et al.
IOVS 2010;51:712-717.
ABSTRACT | FULL TEXT  

Vision-Related Quality of Life and Visual Function after Vitrectomy for Various Vitreoretinal Disorders
Okamoto et al.
IOVS 2010;51:744-751.
ABSTRACT | FULL TEXT  

Responsiveness of NEI VFQ-25 to Changes in Visual Acuity in Neovascular AMD: Validation Studies from Two Phase 3 Clinical Trials
Suner et al.
IOVS 2009;50:3629-3635.
ABSTRACT | FULL TEXT  

Vision related quality of life in multiple sclerosis: correlation with new measures of low and high contrast letter acuity
Mowry et al.
J. Neurol. Neurosurg. Psychiatry 2009;80:767-772.
ABSTRACT | FULL TEXT  

Vision screening for frail older people: a randomised trial
Swamy et al.
Br J Ophthalmol 2009;93:736-741.
ABSTRACT | FULL TEXT  

Improved Vision-Related Function After Ranibizumab vs Photodynamic Therapy: A Randomized Clinical Trial
Bressler et al.
Arch Ophthalmol 2009;127:13-21.
ABSTRACT | FULL TEXT  

Surgical Removal vs Observation for Idiopathic or Ocular Histoplasmosis Syndrome-Associated Subfoveal Choroidal Neovascularization: Vision Preference Value Scale Findings From the Randomized SST Group H Trial: SST Report No. 17
Submacular Surgery Trials Research Group
Arch Ophthalmol 2008;126:1626-1632.
ABSTRACT | FULL TEXT  

Depression and the vision-related quality of life in patients with retinitis pigmentosa
Hahm et al.
Br J Ophthalmol 2008;92:650-654.
ABSTRACT | FULL TEXT  

Improved Vision-Related Function After Ranibizumab Treatment of Neovascular Age-Related Macular Degeneration: Results of a Randomized Clinical Trial
Chang et al.
Arch Ophthalmol 2007;125:1460-1469.
ABSTRACT | FULL TEXT  

Burden and Health Care Resource Utilization in Neovascular Age-Related Macular Degeneration: Findings of a Multicountry Study
Soubrane et al.
Arch Ophthalmol 2007;125:1249-1254.
ABSTRACT | FULL TEXT  

Responsiveness of the National Eye Institute Visual Function Questionnaire to Progression to Advanced Age-Related Macular Degeneration, Vision Loss, and Lens Opacity: AREDS Report No. 14
Age-Related Eye Disease Study Research Group
Arch Ophthalmol 2005;123:1207-1214.
ABSTRACT | FULL TEXT  

Compensatory Strategy Use Identifies Risk of Incident Disability for the Visually Impaired
West et al.
Arch Ophthalmol 2005;123:1242-1247.
ABSTRACT | FULL TEXT  

Surgical Removal vs Observation for Subfoveal Choroidal Neovascularization, Either Associated With the Ocular Histoplasmosis Syndrome or Idiopathic: II. Quality-of-Life Findings From a Randomized Clinical Trial: SST Group H Trial: SST Report No. 10
Submacular Surgery Trials Research Group
Arch Ophthalmol 2004;122:1616-1628.
ABSTRACT | FULL TEXT  

Relative Contributions of Reduced Vision and General Health to NEI-VFQ Scores in Patients With Neovascular Age-Related Macular Degeneration
Miskala et al.
Arch Ophthalmol 2004;122:758-766.
ABSTRACT | FULL TEXT